Diagnostic, Delivery, and Therapy Platform Technology

Our goal is to develop medical devices to improve care for people with serious diseases.

The current focus provides medical researchers with an effective, flexible means to develop treatments and diagnosis through the use of microbubbles.

Microbubbles are a proven medical product used to enhance ultrasound imaging.

Researchers and physicians are beginning to demonstrate the enormous potential of ultrasound and microbubble enhanced therapies – please see resources for a list of publications.

Artenga’s medical device is an
on-demand system to generate microbubbles optimized for therapy.

news

2012:
Novel means to combine microbubbles and targeting biologics developed. Our targeted diagnostic for different cancer types will permit early detection with a simple ultrasound scan and replace multiple needle biopsies. Our targeted therapy will significantly enhance cancer drugs and reduce dose and side effects.

2011:
International Symposium of Therapeutic Ultrasound:

•In vivo evidence that Artenga microbubbles significantly enhance chemotherapy in PC3 prostate cancer

•In vivo localized microbubble payload delivery to tumour

2010:
Cell culture experiments have shown Artenga microbubbles yield a ~10 fold increase in death of breast cancer cells compared to chemotherapy alone.  Abstract can be found (on pg 120) here

2009:
Article on Artenga published in the Ottawa Business Journal.

2008:
Successful therapeutic animal testing.

Artenga has been named one of Canada’s Top 10 Life Science Companies